Работы, цитирующие эту работу

Работ: 3

Работа: Dihydromyricetin Prevents Diabetic Cardiomyopathy via miR-34a Suppression by Activating Autophagy

1. MicroRNA-34a in cardiovascular disease: a glimpse into the future

   Amina M. Alieva, Е. В. Резник, Natalia V. Teplova +4

   СтатьяMicroRNA in disease regulationRussian Cardiology Bulletin2023Цитирований: 0

   ABIABI:AkademIndex/openalex/2023.article.002150

2. Dihydromyricetin: an emerging compound with comprehensive effects on multiple systems

   Chengyi He, Yunfei Chen, Jiao Xie +7

   Обзорная статьяMedicinal plant effects and applicationsFrontiers in Pharmacology2025Цитирований: 0

   ABIABI:AkademIndex/openalex/2025.review-article.000028

3. Dihydromyricetin: A potential candidate for the treatment of cholestatic liver injury via inhibition of the NLRP3 inflammasome

   Hao Zhang, Yiping Dang, Yuanjin Guo +8

   СтатьяMedicinal plant effects and applicationsEuropean Journal of Pharmacology2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.015269